Skip to main content

Table 2 Metabolic activity differences between ND and BG high (Effect size > 0.1)

From: Schizophyllum commune-derived β-glucan improves intestinal health demonstrating protective effects against constipation and common metabolic disorders

Enriched group

Pathways

Descriptions

Effect size difference

BG_high

SALVADEHYPOX-PWY

Adenosine nucleotides degradation II

0.24

BG_high

PWY-6608

Guanosine nucleotides degradation III

0.22

BG_high

P161-PWY

Acetylene degradation

0.15

BG_high

PWY-1861

Formaldehyde assimilation II (RuMP Cycle)

0.15

BG_high

PWY-5347

Superpathway of L-methionine biosynthesis (transsulfuration)

0.13

BG_high

PWY-6353

Purine nucleotides degradation II (aerobic)

0.13

BG_high

P4-PWY

Superpathway of L-lysine, L-threonine and L-methionine biosynthesis I

0.12

BG_high

PWY-6901

Superpathway of glucose and xylose degradation

0.12

BG_high

PWY0-781

Aspartate superpathway

0.11

BG_high

MET-SAM-PWY

Superpathway of S-adenosyl-L-methionine biosynthesis

0.11

BG_high

RUMP-PWY

Formaldehyde oxidation I

0.10

ND

PWY-5838

Superpathway of menaquinol-8 biosynthesis I

0.17

ND

PWY-5840

Superpathway of menaquinol-7 biosynthesis

0.16

ND

PWY-5899

Superpathway of menaquinol-13 biosynthesis

0.16

ND

PWY-5897

Superpathway of menaquinol-11 biosynthesis

0.16

ND

PWY-7315

dTDP-N-acetylthomosamine biosynthesis

0.13

ND

PWY-5861

Superpathway of demethylmenaquinol-8 biosynthesis

0.13

ND

FASYN-ELONG-PWY

Fatty acid elongation—saturated

0.11

ND

P108-PWY

Pyruvate fermentation to propanoate I

0.10